These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evidence of an antigen common to human intestine, endocervix and mucinous ovarian cysts present exclusively in ALeb patients. Bara J; Mollicone R; Le Pendu J; Oriol R; Burtin P Bull Cancer; 1985; 72(2):104-7. PubMed ID: 2408696 [No Abstract] [Full Text] [Related]
8. Identification of tumor-associated antigens and their purification for cyst fluids of ovarian epithelial neoplasms. Dawson JR; Kutteh WH; Whitesides DB; Gall SA Gynecol Oncol; 1980 Aug; 10(1):6-17. PubMed ID: 6772525 [No Abstract] [Full Text] [Related]
9. Detection of tumor-specific antigens in human mucinous cystadenocarcinoma of the ovary by immunodiffusion. Chow SN; Chiang WT; Wei PY Int J Gynaecol Obstet; 1976; 14(3):280-4. PubMed ID: 13019 [TBL] [Abstract][Full Text] [Related]
10. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors. Bhattacharya M; Barlow JJ Am J Obstet Gynecol; 1973 Nov; 117(6):849-53. PubMed ID: 4126800 [No Abstract] [Full Text] [Related]
11. Quantitation of antigens in normal and malignant ovarian tissue. Knauf S; Urbach GI Am J Obstet Gynecol; 1975 Oct; 123(3):302-4. PubMed ID: 1180293 [TBL] [Abstract][Full Text] [Related]
12. [Studies on the serum levels of a carbohydrate antigen 19-9 (CA 19-9) in patients with ovarian cancer]. Miyoshi T; Nishimura H; Ookura N; Morisaki H; Kobayashi H; Tasaki T; Ushijima H; Yakushiji M Igaku Kenkyu; 1984 Dec; 54(8):796-800. PubMed ID: 6599577 [No Abstract] [Full Text] [Related]
13. [Distribution and diagnostic role of COTA in mucinous ovarian tumors]. Shi ZL Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):191-2. PubMed ID: 2612330 [TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity between Candida albicans and human ovarian carcinoma as revealed by monoclonal antibodies PA10F and C6. Schneider J; Moragues D; Martínez N; Romero H; Jimenez E; Pontón J Br J Cancer; 1998 Mar; 77(6):1015-20. PubMed ID: 9528850 [TBL] [Abstract][Full Text] [Related]
15. Antigenicity of a papillary serous cystadenocarcinoma tissue homogenate and its fractions. Levi MM; Keller S; Mandl I Am J Obstet Gynecol; 1969 Nov; 105(6):856-61. PubMed ID: 4186861 [No Abstract] [Full Text] [Related]
16. CA 125 and TPA as markers in ovarian carcinoma. Rodenburg CJ; De Maaker GA; Trimbos JB; Moolenaar AJ; Van Oosterom AT Neth J Med; 1985; 28(12):536-40. PubMed ID: 2418375 [No Abstract] [Full Text] [Related]
17. Analysis of human ovarian tumor antigens using heterologous antisera: detection of new antigenic systems. Imamura N; Takahashi T; Lloyd KO; Lewis JL; Old LJ Int J Cancer; 1978 May; 21(5):570-7. PubMed ID: 77848 [No Abstract] [Full Text] [Related]
19. A monoclonal antibody radioimmunoassay for an antigenic determinant CA125 in ovarian cancer patients. Lian LJ; Hu XF; Liu WS; Wu AJ Chin Med J (Engl); 1986 Sep; 99(9):721-6. PubMed ID: 2433106 [No Abstract] [Full Text] [Related]
20. An ovarian tumour specific mucin antigen--immunohistological and biochemical studies. Ma J; Handley CJ; de Boer WG Pathology; 1983 Oct; 15(4):385-91. PubMed ID: 6371680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]